Royal Fund Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $779K | Buy |
7,027
+4,015
| +133% | +$445K | 0.08% | 187 |
|
|
2025
Q1 | $338K | Buy |
+3,012
| New | +$338K | 0.04% | 220 |
|
|
2024
Q4 | – | Sell |
-22,140
| Closed | -$1.86M | – | 245 |
|
|
2024
Q3 | $1.86M | Buy |
22,140
+2,577
| +13% | +$216K | 0.11% | 148 |
|
|
2024
Q2 | $1.34M | Sell |
19,563
-2,877
| -13% | -$197K | 0.11% | 147 |
|
|
2024
Q1 | $1.64M | Buy |
22,440
+7,624
| +51% | +$558K | 0.16% | 140 |
|
|
2023
Q4 | $1.2M | Buy |
+14,816
| New | +$1.2M | 0.13% | 160 |
|
|
2020
Q2 | – | Sell |
-2,779
| Closed | -$207K | – | 295 |
|
|
2020
Q1 | $207K | Sell |
2,779
-2,853
| -51% | -$213K | 0.08% | 139 |
|
|
2019
Q4 | $365K | Sell |
5,632
-709
| -11% | -$45.9K | 0.09% | 100 |
|
|
2019
Q3 | $401K | Buy |
6,341
+29
| +0.5% | +$1.83K | 0.11% | 94 |
|
|
2019
Q2 | $426K | Buy |
6,312
+4,026
| +176% | +$272K | 0.13% | 87 |
|
|
2019
Q1 | $148K | Buy |
2,286
+1,165
| +104% | +$75.4K | 0.05% | 140 |
|
|
2018
Q4 | $70K | Sell |
1,121
-5,278
| -82% | -$330K | 0.03% | 164 |
|
|
2018
Q3 | $494K | Buy |
6,399
+176
| +3% | +$13.6K | 0.15% | 79 |
|
|
2018
Q2 | $440K | Sell |
6,223
-21,471
| -78% | -$1.52M | 0.15% | 79 |
|
|
2018
Q1 | $2.09M | Buy |
27,694
+24,488
| +764% | +$1.85M | 0.76% | 38 |
|
|
2017
Q4 | $229K | Buy |
+3,206
| New | +$229K | 0.08% | 105 |
|
|
2017
Q2 | – | Sell |
-50
| Closed | -$3K | – | 465 |
|
|
2017
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 344 |
|
|
2016
Q4 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 328 |
|